The role of donor-recipient relationship in long-term outcomes of living donor renal transplantation

Transplantation

Volumn 85, Issue 10, 2008, Pages 1483-1488

  Miles, Clifford D ^a   Schaubel, Douglas E ^b,c   Liu, Dandan ^b   Port, Friedrich K ^c,d   Rao, Panduranga S ^c,e,f  

^a NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c Scientific Registry of Transplant Recipients   (United States)

^d ARBOR RESEARCH COLLABORATIVE FOR HEALTH   (United States)

^e UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^f 102 Observatory   (United States)

Author keywords

Graft survival; Kidney transplantation; Living related donation; Microchimerism; Tolerance

Indexed keywords

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CHRONIC GRAFT REJECTION; DONOR SELECTION; FEMALE; FETOMATERNAL TRANSFUSION; GRAFT FAILURE; GRAFT SURVIVAL; HAPLOTYPE; HLA SYSTEM; HUMAN; IMMUNOLOGICAL TOLERANCE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MICROCHIMERISM; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGENY; PROPORTIONAL HAZARDS MODEL; REGISTER; ADOLESCENT; CHILD; CHILD PARENT RELATION; FOLLOW UP; METHODOLOGY; MIDDLE AGED; MORTALITY; NUCLEAR FAMILY; PSYCHOLOGICAL ASPECT; RETROSPECTIVE STUDY; SIBLING; SURVIVAL; TIME;

ADOLESCENT; ADULT; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; NUCLEAR FAMILY; PARENT-CHILD RELATIONS; RESEARCH DESIGN; RETROSPECTIVE STUDIES; SIBLINGS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 48649094334     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181705a0f     Document Type: Article

References (37)

1. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725.
2. Danovitch GM, Cohen DJ, Weir MR, et al. Current status of kidney and pancreas transplantation in the United States, 1994-2003. Am J Transplant 2005; 5: 904-915.
3. Port FK, Bragg-Gresham JL, Metzger RA, et al. Donor characteristics associated with reduced graft survival: An approach to expanding the pool of kidney donors. Transplantation 2002; 74: 1281.
4. Cohen DJ, St. Martin L, Christensen LL, et al. Kidney and pancreas transplantation in the United States, 1995-2004.AmJ Transplant 2006; 6: 1153-1169.
5. Chapman JR, O'Connell PJ, Nankivell BJ. Chronic renal allograft dysfunction. J Am Soc Nephrol 2005; 16: 3015.
6. Bowman JM, Pollock JM, Penston LE. Fetomaternal trans-placental hemorrhage during pregnancy and after delivery. Vox Sang 1986; 51: 117.
7. Liegeois A, Gaillard MC, Ouvre E, et al. Microchimerism in pregnant mice. Transplant Proc 1981; 13: 1250.
8. Bianchi DW, Zickwolf GK, Weil GJ, et al. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci USA 1996; 93: 705.
9. O'Donoghue K, Chan J, de la Fuente J, et al. Microchimerism in female bone marrow and bone decades after fetal mesenchymal stem-cell trafficking in pregnancy. Lancet 2004; 364: 179.
10. Maloney S, Smith A, Furst DE, et al. Microchimerism of maternal origin persists into adult life. J Clin Invest 1999; 104: 41.
11. Lambert NC, Erickson TD, Yan Z, et al. Quantification of maternal microchimerism by HLA-specific real-time polymerase chain reaction. Arthritis Rheum 2004; 50: 906.
12. Johnson KL, Bianchi DW. Fetal cells in maternal tissue following pregnancy: What are the consequences? Hum Reprod Update 2004; 10: 497.
13. Adams KM, Nelson JL. Microchimerism: An investigative frontier in autoimmunity and transplantation. JAMA 2004; 291: 1127.
14. Mahanty HD, Cherikh WS, Chang GJ, et al. Influence of pretransplant pregnancy on survival of renal allografts from living donors. Transplantation 2001; 72: 228.
15. Opelz G, for the Collaborative Transplant Study. Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies. Lancet 2005; 365: 1570.
16. Rosenberg JC, Jones B, Oh H. Accelerated rejection following offspring-to-mother and husband-to-wife transplants. Clin Transplant 2004; 18: 729.
17. van Rood JJ, Loberiza FR Jr, Zhang M, et al. Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLAhaploidentical sibling. Blood 2002; 99: 1572.
18. Ichinohe T, Uchiyama T, Shimazaki C, et al. Feasibility of HLAhaploidentical hematopoietic stem cell transplantation between noninherited maternal antigen (NIMA)-mismatched family members linked with long-term fetomaternal microchimerism. Blood 2004; 104: 3821.
19. Matsuoka K, Ichinohe T, Hashimoto D, et al. Fetal tolerance to maternal antigens improves the outcome of allogeneic bone marrow transplantation by a CD4-CD25- T-cell-dependent mechanism. Blood 2006; 107: 404.
20. Tamaki S, Ichinohe T, Matsuo K, et al. Superior survival of blood and marrow stem cell recipients given maternal grafts over recipients given paternal grafts. Bone Marrow Transplant 2001; 28: 375.
21. Burlingham WJ, Grailer AP, Heisey DM, et al. The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors. N Engl J Med 1998; 339: 1657.
22. Starzl TE. Chimerism and tolerance in transplantation. Proc Natl Acad Sci USA 2004; 101: 14607.
23. HHS/HRSA/HSB/DOT. 2005 OPTN/SRTR Annual Report 1995-2004. www.ustransplant.org
24. The 12th Report of the Human Renal Transplant Registry. JAMA 1975; 233: 787.
25. Simmons RL, Kjellstrand CM, Condie RM, et al. Parent-to-child and child-to-parent kidney transplants: Experience with 101 transplants at one centre. Lancet 1976; 1: 321.
26. Cohen EP, Rosendale JD, Bong CJH, et al. Benefit of child-to-parent kidney donation. Am J Transplant 2003; 3: 865.
27. Cecka JM. Living donor transplants. Clin Transpl 1995; 363.
28. Inman B, Halloran B, Melk A, et al. Microchimerism in sensitized renal patients. Transplantation 1999; 67: 1381.
29. Tan JC, Wadia P, Grumet FC, et al. A role for antibodies against minor histocompatibility antigens in acute rejection. World Transplant Congress 2006 Oral Abstracts. Am J Transplant 2006; 6: 65-472.
30. Opelz G. Analysis of the "NIMA effect" in renal transplantation. Clin Transpl 1990. P. Terasaki, Ed. UCLA Tissue Typing Laboratory, Los Angeles, CA.
31. Kalia A, Dobbins JG, Brouhard BH, et al. Sex of the parental donor and cellular rejection of renal allografts in children. Transplantation 1988; 46: 70.
32. Neu AM, Stablein DM, Zachary A, et al. Effect of parental donor sex on rejection in pediatric renal transplantation: A report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplantation 1998; 2: 309.
33. Zeier M, Dohler B, Opelz G, et al. The effect of donor gender on graft survival. J Am Soc Nephrol 2002; 13: 2570.
34. Kayler LK, Rasmussen CS, Dykstra DM, et al. Gender imbalance and outcomes in living donor renal transplantation in the United States. Am J Transplant 2003; 3: 452.
35. Oh CK, Lee BM, Kim HJ, et al. Gender-related differences of renal mass supply and metabolic demand after living donor kidney transplantation. Clin Transplant 2006; 20: 163.
36. Campbell DA, Lorber MI, Sweeton JC, et al. Breast feeding and maternal donor allografts. Possibly the original donor-specific transfusion. Transplantation 1984; 37: 340.
37. Molitor ML, Burlingham WJ. Immunobiology of exposure to noninherited maternal antigens. Front Biosci 2007; 12: 3302.